Genetic and phenotypic characterization of pyrazinamide-resistant Mycobacterium tuberculosis complex isolates in Japan

被引:24
|
作者
Miyagi, C [1 ]
Yamane, N
Yogesh, B
Ano, H
Takashima, T
机构
[1] Univ Ryukyus, Fac Med, Dept Lab Med, Okinawa, Japan
[2] Osaka Prefectural Habikino Hosp, Osaka, Japan
关键词
D O I
10.1016/j.diagmicrobio.2003.09.013
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The pncA gene mutations associated with pyrazinamide (PZA) resistance in Mycobacterium tuberculosis complex were determined in 26 PZA-resistant isolates in Japan. Of the 26 PZA-resistant isolates included, 21 were negative for pyrazinamidase (PZase). Of these, 20 isolates had various pncA mutations, resulting in alteration of primary amino acid sequence. However, 1 PZase-negative isolate did not have any mutation on pncA gene. The remaining 5 PZA-resistant isolates were positive for PZase and had identical pncA alleles with PZA-susceptible isolates. IS6110 RFLP analysis demonstrated various distinct IS6110 types and 5 pairs of isolates were very close to each other (>90% identical pattern). This study demonstrates that most of the PZA resistance is a result of various mutations on pncA resulting in loss of PZase activity. Further investigation, particularly on PZase-positive but PZA-resistant isolates and a PZase-negative isolate with no mutation on pncA, should be urgently done. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:111 / 116
页数:6
相关论文
共 50 条
  • [31] Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis clinical isolates in Hangzhou, China
    Liu, W.
    Chen, J.
    Shen, Y.
    Jin, J.
    Wu, J.
    Sun, F.
    Wu, Y.
    Xie, L.
    Zhang, Y.
    Zhang, W.
    CLINICAL MICROBIOLOGY AND INFECTION, 2018, 24 (09) : 1016.e1 - 1016.e5
  • [32] Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis in Brazil (vol 49, pg 444, 2005)
    Rodrigues, Vivian de F. Sumnienski
    Telles, Maria Alice
    Ribeiro, Marta Osorio
    Cafrune, Patricia Izquierdo
    Rossetti, Maria Lucia Rosa
    Zaha, Arnaldo
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (11) : 3970 - 3970
  • [33] Multicenter Study of the Emergence and Genetic Characteristics of Pyrazinamide-Resistant Tuberculosis in China
    Li, Dange
    Hu, Yi
    Werngren, Jim
    Mansjo, Mikael
    Zheng, Xubin
    Drobniewski, Francis
    Hoffner, Sven
    Xu, Biao
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (09) : 5159 - 5166
  • [34] The pncA gene from naturally pyrazinamide-resistant Mycobacterium avium encodes pyrazinamidase and confers pyrazinamide susceptibility to resistant M-tuberculosis complex organisms
    Sun, ZH
    Scorpio, A
    Zhang, Y
    MICROBIOLOGY-SGM, 1997, 143 : 3367 - 3373
  • [35] Rapid detection of pyrazinamide-resistant Mycobacterium tuberculosis by a PCR-based in vitro system
    Suzuki, Y
    Suzuki, A
    Tamaru, A
    Katsukawa, C
    Oda, H
    JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (02) : 501 - 507
  • [36] Non-pncA Gene-Mutated but Pyrazinamide-Resistant Mycobacterium tuberculosis: Why Is That?
    Werngren, Jim
    Alm, Erik
    Mansjo, Mikael
    JOURNAL OF CLINICAL MICROBIOLOGY, 2017, 55 (06) : 1920 - 1927
  • [37] Draft Genome Sequences of Two Pyrazinamide-Resistant Clinical Isolates, Mycobacterium tuberculosis 13-4152 and 13-2459
    Maslov, D. A.
    Shur, K. V.
    Bekker, O. B.
    Zakharevich, N. V.
    Zaichikova, M. V.
    Klimina, K. M.
    Smirnova, T. G.
    Zhang, Y.
    Chernousova, L. N.
    Danilenko, V. N.
    GENOME ANNOUNCEMENTS, 2015, 3 (04)
  • [38] Characterization of new mutations in pyrazinamide-resistant strains of Mycobacterium tuberculosis and identification of conserved regions important for the catalytic activity of the pyrazinamidase PncA
    Lemaitre, N
    Sougakoff, W
    Truffot-Pernot, C
    Jarlier, V
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (07) : 1761 - 1763
  • [39] Phenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol
    Parsons, LA
    Salfinger, M
    Clobridge, A
    Dormandy, J
    Mirabello, L
    Polletta, VL
    Sanic, A
    Sinyavskiy, O
    Larsen, SC
    Driscoll, J
    Zickas, G
    Taber, HW
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (06) : 2218 - 2225
  • [40] Treatment Outcomes of Pulmonary Pyrazinamide-Resistant Multidrug-Resistant Tuberculosis
    Park, S.
    Ji, W.
    Jo, K.
    Shim, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197